Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
Dillard's (DDS): Assessing the Path to a $700 Technical Target

Dillard's (DDS): Assessing the Path to a $700 Technical Target

Key Takeaways

  • Dillard's, Inc. (DDS), the Arkansas-based department-store retailer, recently traded near $600, within a 52-week range of roughly $503 to $742.
  • The $700 target here is not an analyst consensus. It is a fallback objective drawn from public discussion and technical structure—a round-number resistance level just below the stock's 52-week high—because the limited analyst coverage does not support a usable above-price target.
  • Reaching $700 from a price near $602 would require a gain of about 16%, a substantial move for a mature retailer.
  • Only three firms publish current targets—UBS ($468), J.P. Morgan ($519), and Telsey Advisory Group ($650)—averaging roughly $546, all at or below recent prices and consistent with a Moderate Sell consensus.
  • The strongest supports are exceptional profitability, a conservative cash-rich balance sheet, and a recent earnings beat.
  • The biggest risks are persistent revenue contraction, margin normalization, and structural headwinds facing the department-store industry.
  • For more on this stock, explore Major News, Today's Price Move, Forecast, and Earnings pages for the latest developments.
  • Readers can also explore Trending AI Robots to see which automated strategies are active across the market.

How the $700 Target Was Established

Dillard's is a stock, but its analyst coverage is unusually thin. Three firms maintain current 12-month price targets: UBS (Sell, $468), J.P. Morgan (Sell, $519), and Telsey Advisory Group (Hold, $650). The arithmetic mean is about $546, with a range of $468 to $650. Because every one of these targets sits at or below the stock's recent trading price near $600, no meaningful above-price consensus exists, and the minimum-distance rule cannot be satisfied with analyst data.

For that reason, the $700 figure used here is not an analyst price target. It reflects a publicly discussed technical objective: a round-number, psychological resistance level that sits just beneath the stock's 52-week high of $741.98 and near the roughly $695 area where DDS traded in late October. It is a reference point, not a prediction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

With the stock near $602 in early November 2026, moving to $700 would represent roughly 16% upside. On a strict percentage basis, that is a substantial move rather than a modest drift. The company's fundamentals are a study in contrast: DDS remains highly profitable, with trailing EPS (earnings per share) near $43 and a trailing P/E (price-to-earnings) ratio in the mid-teens, yet revenue has contracted for multiple fiscal years, from about $6.87 billion to roughly $6.6 billion.

A path toward $700 would likely require the stock to reclaim and hold prior breakout zones in the upper $600s before challenging the 52-week high. That, in turn, would depend on evidence that the company can stabilize sales and defend margins, which have moderated from prior peaks.

What Could Support a Move Toward the Target

  • Exceptional profitability: Dillard's posts a roughly 10% net margin and a return on equity above 30%, well above most department-store peers.
  • Conservative balance sheet: With roughly $1.26 billion in cash against about $457 million in debt, the company has substantial financial flexibility.
  • Earnings execution: The August 2026 quarter delivered EPS of $4.43, beating the $4.29 consensus, with revenue also slightly ahead of estimates.
  • Technical momentum: The stock traded near $695 in late October, showing it can approach the $700 zone during upswings.

What Could Prevent the Target From Being Reached

  • Revenue contraction: A multi-year sales decline suggests weaker traffic and demand rather than a one-off soft quarter.
  • Margin normalization: Profitability, while still strong, has eased from prior-cycle peaks, reducing the earnings cushion.
  • Bearish analyst stance: UBS and J.P. Morgan both rate the stock Sell, citing structural headwinds in the department-store sector.
  • Valuation and sentiment: A Moderate Sell consensus and persistent insider selling point to limited conviction in further upside.

Technical Levels and Market Structure

The 52-week range of $503.06 to $741.98 frames the picture. The $700 area acts as psychological resistance just under the $742 high, while support sits near the $600 round number and the mid-$500s zone. A durable move toward $700 would first require clearing the upper-$600s supply zone that has capped rallies; failure to hold $600 could shift focus back toward the $503 low.

Time Horizon and What Investors Should Monitor

Analyst targets typically reflect a roughly 12-month horizon, and the three DDS targets are no exception, though they diverge widely—from $468 to $650—reflecting disagreement over whether the company can defend its profitability as sales decline. Investors should watch the fiscal third-quarter earnings report due in early-to-mid November, guidance on comparable-store sales and margins, any revisions from the three covering firms, and broader consumer-spending data and rate decisions that influence discretionary retail.

Using AI Daily Buy/Sell Signals in My Research

I often rely on Tickeron's AI Daily Buy/Sell Signals to monitor stocks like this one. The tool uses artificial intelligence to scan thousands of equities and ETFs, producing Buy, Sell, or Hold signals based on shifting technical conditions and market dynamics. For a name with thin coverage such as DDS, these signals offer an efficient way to track daily positioning and trend changes alongside conventional analysis.

Final Assessment

Can Dillard's (DDS) stock reach $700? The question is best answered with context, not certainty. The $700 level is a technical and psychological objective—not a published analyst consensus—and reaching it from around $602 would require a substantial move of roughly 16%. Supporting the case are Dillard's remarkable profitability, strong balance sheet, and recent earnings beat, while the case against rests on persistent revenue declines, moderating margins, and a broadly bearish analyst stance. With three analysts holding targets at or below the current price and a wide $468-to-$650 range, conviction is clearly limited. The most important near-term catalysts are the upcoming earnings report and any shifts in sales trends or analyst revisions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DDS

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


DDS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 03, 2026

DDS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 28 cases where DDS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 57 cases where DDS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

Following a +6.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where DDS advanced for three days, in 248 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 201 of 264 cases where DDS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The 10-day RSI Indicator for DDS moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In 31 of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DDS as a result. In 63 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for DDS turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 34 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.

DDS moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DDS crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DDS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.437) is normal, around the industry mean (-9.611). P/E Ratio (13.803) is within average values for comparable stocks, (-121.526). DDS's Projected Growth (PEG Ratio) (0.020) is slightly lower than the industry average of (1.329). DDS has a moderately low Dividend Yield (0.002) as compared to the industry average of (0.032). P/S Ratio (1.532) is also within normal values, averaging (19.276).

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. DDS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Macy's (NYSE:M), Kohls Corp (NYSE:KSS).

Industry description

A department store sells a wide variety of consumer goods under different “departments,” including (but not necessarily limited to) apparel, household appliances, home furnishings, personal care products, cosmetics, consumer electronics. During healthy macroeconomic conditions, consumers typically won’t shy away from big-ticket purchases; but during a downturn, consumer spending might get limited to the most necessary/daily essentials. Several department stores purchase items on bulk from manufacturers for resale to consumers at a profit. Some of the largest department stores companies in the U.S. include Kohl’s Corporation, Macy’s Inc., and Ollie’s Bargain Outlet Holdings Inc.

Market Cap

The average market capitalization across the Department Stores Industry is 5B. The market cap for tickers in the group ranges from 208.1K to 7.88T. MHRTF holds the highest valuation in this group at 7.88T. The lowest valued company is BONT at 208.1K.

High and low price notable news

The average weekly price growth across all stocks in the Department Stores Industry was 1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 28%. KSS experienced the highest price growth at 3%, while PLBL experienced the biggest fall at -1%.

Volume

The average weekly volume growth across all stocks in the Department Stores Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 35% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 60
Price Growth Rating: 52
SMR Rating: 73
Profit Risk Rating: 78
Seasonality Score: -1 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator of a chain of departmental stores

Industry DepartmentStores

Industry
Department Stores
Address
1600 Cantrell Road
Phone
+1 501 376-5200
Employees
29100
Web
https://www.dillards.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.
CCAP climbed +7.03% during regular market hours, rising from a prior close of $9.24 to $9.89. The rally followed its Q3 2026 report: net investment income of $0.37/share beat the $0.35 consensus and revenue of $36.9M topped estimates, alongside a new $50M buyback authorization plus up to $25M in additional Sun Life purchases.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
The central stock price target of $100 is the arithmetic mean of the verified analyst price targets reviewed; major aggregators report a similar consensus near $99–$102, with a wide range from roughly $60 to $150. With the stock trading near $53, reaching $100 would require a gain of approximately 88% — a very large move from current levels.